New cancer clinical trial: A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer

Published on: January 21, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share